NCT00347295View on ClinicalTrials.gov

Randomised, Double-blind Study to Investigate the Safety and Efficacy of Brotizolam in Insomnia Outpatients.

PHASE3CompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

Brotizolam

DRUG

Estazolam

Trial Locations (8)

100083

Third Hospital of Beijing Hospital, Beijing

100088

Beijing Anding Hospital, Beijing

100730

Beijing Hospital, Beijing

Peking Union Medical College Hospital, Beijing

200030

Shanghai Mental Health Center, Shanghai

200040

Hu Shan Hospital, Fu Dan University, Shanghai

200065

Tongji Hospital, Tongji University, Shanghai

510370

Guanzhou Psychiatric Hospital, Guangzhou

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00347295 - Randomised, Double-blind Study to Investigate the Safety and Efficacy of Brotizolam in Insomnia Outpatients. | Biotech Hunter | Biotech Hunter